Gotham Therapeutics logo

Gotham Therapeutics

A biotechnology company discovering drugs that target the epitranscriptomics machinery that modifies RNA.

1

Funding Rounds

$54.0m

Money raised

Overview

A biotechnology company discovering drugs that target the epitranscriptomics machinery that modifies RNA.

Funding series

Funding Series Analysis

The company Gotham Therapeutics has raised a total of $54m in funding over 1 rounds.

Key Insights:

  • Gotham Therapeutics funding round, October 2018: $54m
Gotham Therapeutics logo
Gotham Therapeutics funding round, October 2018 $54m

Industries

Gotham Therapeutics is active in the following industries: